ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Cromabak® 2%:Théa PHARMA S.A.
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
S01GX01 - Cromoglicic AcidATC-DDD Version 2016. Source: WHO
S - Sensory Organs

A formulation approved both for use in the eye/ear is classified in S03. Formulations approved for eye, ear and nose are also classified in S03. Formulations only licensed for use in the eye or the ear are classified in S01 and S02, respectively.

S01 - Ophthalmologicals

Most of the drugs in this group are topical preparations. Systemic preparations with clear ophthalmological indications are also classified in this group.
Small amounts of antiseptics in eye preparations do not influence the classification, e.g. benzalconium.
See also S03 - Ophthalmological and otological preparations.

DDDs have been assigned for antiglaucoma preparations only.

S01G - Decongestants and Antiallergics

This group comprises drugs used to treat symptoms of e.g. allergy.

S01GX - Other Antiallergics

Combinations of cromoglicic acid and antihistamines are classified in S01GX51.

S01GX01 - Cromoglicic Acid
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home